Sorrento Therapeutics, Inc.(NASDAQ : SRNE)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|REGN||Regeneron Pharmaceuticals, Inc.||1.32%||697.33||2.6%||$644.85m|
|GILD||Gilead Sciences, Inc.||-1.43%||62.86||1.0%||$494.49m|
|VRTX||Vertex Pharmaceuticals, Inc.||-1.01%||283.45||1.9%||$355.83m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-5.81%||4.05||0.7%||$283.11m|
|SAVA||Cassava Sciences, Inc.||-18.00%||41.87||0.0%||$173.71m|
|NRBO||NeuroBo Pharmaceuticals, Inc.||-6.44%||15.54||0.0%||$89.03m|
|BMRN||BioMarin Pharmaceutical, Inc.||-0.09%||84.84||4.2%||$76.07m|
|EXAS||EXACT Sciences Corp.||-2.74%||33.41||17.6%||$71.49m|
|CRSP||CRISPR Therapeutics AG||-2.68%||63.16||0.6%||$69.53m|
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.